Medication-assisted treatment (MAT) for opioid use disorder (OUD);has been referred to as the "gold standard" (see;Facing Addiction In America: The Surgeon General’s Spotlight On Opioids) for treatment. But that endorsement hasn’t been enough to drive the adoption of MAT. Health and human service (HHS) executives—at the policy and practice level—are trying to drive the use of medications in treatment—but the barriers are many.

Recent research,;Understanding MAT Access In The Context Of Unused MAT Capacity In The United States: When Increasing Rural MAT Capacity Is Not Enough, looked at . . .

Want To Read More? Log In Or Become A Free Member
Resource Available For All OPEN MINDS Circle Members
If you are already a member, log in to your account to access this resource and more.

You can become a free member and get access now. Learn more about the OPEN MINDS Circle Market Intelligence Service Membership. Reach out to our team at info@openminds.com, or call us at 877-350-6463.

A Paid OPEN MINDS Circle Membership provides unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!